Phase I/II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Vorinostat (Primary) ; Isotretinoin; Temozolomide
- Indications Anaplastic astrocytoma; Glioblastoma; Gliosarcoma
- Focus Adverse reactions
- 28 Sep 2017 Planned End Date changed from 1 Nov 2016 to 1 Nov 2019.
- 28 Sep 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Nov 2019.
- 07 Mar 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2017 as reported by ClinicalTrials.gov record.